Fulvestrant Pliva

Fulvestrant Pliva is a pharmaceutical product used for specific therapeutic purposes. Manufactured by Pliva Hrvatska D.O.O., it is available in various forms for different routes of administration.

Fulvestrant Pliva is primarily used for hormone receptor-positive metastatic breast cancer. It works by blocking the effects of estrogen in the body, which can help slow the growth of certain types of breast cancer cells. This medication is often considered when other treatments have not been effective or are no longer suitable.

Common effects of Fulvestrant Pliva may include injection site reactions, such as pain, swelling, or redness. Some individuals might experience fatigue, nausea, or headaches. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Fulvestrant Pliva should be handled with care, following the prescribed administration route. It is important to inform healthcare providers about any allergies or medical conditions before starting treatment. Proper storage and disposal of the medication are crucial to ensure safety and effectiveness.

Fulvestrant Pliva may interact with certain medications, including those that affect liver enzymes. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol and other substances that affect liver function should be used cautiously.